Skip to main content

Animations

MJFF Publications

471 - 480 of 6403 Results
Title
Year
  • Year
  • 2010
  • 2016
  • 2010
  • 2008
  • 2009
  • 2009
  • 2016
  • 2010
  • 2013
  • 2010
  • Summary Details
    OPEN
    Title: Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.3000664
    Citation Count: 135
  • Summary Details
    OPEN
    Title: Ser(P)‐1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26686
    Citation Count: 181
  • Summary Details
    OPEN
    Title: Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.12.018
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.21425
    Citation Count: 719
  • Summary Details
    OPEN
    Title: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways
    Journal Name: Synapse
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/syn.20725
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/1750-1326-4-34
    Citation Count: 90
  • Summary Details
    OPEN
    Title: Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson’s disease patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep30793
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
    Journal Name: Molecular and Cellular Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.mcn.2010.12.011
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25647
    Citation Count: 136
  • Summary Details
    OPEN
    Title: α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease
    Journal Name: Neuroepidemiology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000315157
    Citation Count: 62
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.